Vti1A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Vti1A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
VTI1A (Vesicular Transport Interactor 1A) is a soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) protein involved in intracellular membrane trafficking. Originally identified as a component of the vesicle transport machinery, VTI1A has emerged as an important protein in synaptic function and has been implicated in neurodegenerative diseases through its role in autophagy, lysosomal trafficking, and protein homeostasis. This page covers the VTI1A gene structure, protein function, and its involvement in Alzheimer's Disease, Parkinson's Disease, and other neurodegenerative conditions. [@lee2019]
Gene Information
Gene Structure
The VTI1A gene consists of 8 exons spanning approximately 10 kb of genomic DNA. The gene encodes a protein with 193 amino acids containing an N-terminal Habc domain and a C-terminal transmembrane region typical of Q<sub>c</sub>-SNAREs.
Isoforms
Isoform 1 (canonical): 193 amino acids
Isoform 2: Alternative splicing variant
Protein Function
VTI1A functions as a Q<sub>c</sub>-SNARE (glutamine-containing SNARE) in intracellular trafficking:
SNARE Complex Formation
VTI1A forms SNARE complexes with:
Syntaxin: Q<sub>a</sub>-SNARE partner
SNAP-25/23: Q<sub>b</sub>-SNARE partner
The resulting four-helix bundle drives membrane fusion.
Key Functions
Vesicle Trafficking: Mediates vesicular transport between intracellular compartments
[Autophagy](/entities/autophagy): Involved in autophagosome formation and maturation
Lysosomal Function: Regulates trafficking to lysosomes
Synaptic Vesicle Cycling: Participates in neurotransmitter release
Endosomal Trafficking: Controls endocytic pathway
Tissue Expression
Brain: High expression in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), cerebellum
[Neurons](/entities/neurons): Dendritic and axonal compartments
[α-Synuclein](/proteins/alpha-synuclein) Trafficking: Role in α-synuclein secretion and spread
Autophagy Impairment: Reduced autophagic flux
Dopaminergic Vulnerability: Specific effects on dopaminergic neurons
ALS (Amyotrophic Lateral Sclerosis)
Protein Aggregation: Impaired protein quality control
Vesicle Transport Defects: Axonal transport abnormalities
Autophagy Dysfunction: Aggregate clearance issues
Therapeutic Implications
Targeting Strategies
Challenges
Complex SNARE biology
Multiple binding partners
Timing of intervention
Research Directions
Understanding VTI1A in specific neuron types
SNARE complex composition in disease
Therapeutic modulation of SNARE function
Biomarker development
Background
The study of Vti1A Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
VTI1A Protein - VTI1A protein product
SNARE Complex - SNARE proteins
Autophagy Pathway - Protein clearance
[Alzheimer's Disease](/diseases/al- [Parkinson's Disease](/diseases/parkinsons-disease) in AD
[Parkinson's Disease](/diseases/parkinsons-disease) VTI1A in PD